ATOS - Atossa stock jumps 16% in wake of Cantor overweight rating
2023-09-08 12:29:30 ET
More on Atossa Therapeutics
- Seeking Alpha’s Quant Rating on Atossa Therapeutics
- Historical earnings data for Atossa Therapeutics
- Financial information for Atossa Therapeutics
- Atossa Therapeutics: Betting Big On Transforming Old Breast Cancer Care
- Atossa Therapeutics, Inc. ( ATOS ) Q2 2023 Earnings Call Transcript
- Atossa gains as Canada greenlights breast cancer trial
- Atossa jumps 17% after update on mid-stage trial for breast cancer drug
For further details see:
Atossa stock jumps 16% in wake of Cantor overweight rating